Bexion Pharmaceuticals Revenue and Competitors

Covington, KY

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Bexion Pharmaceuticals's estimated annual revenue is currently $5.3M per year.(i)
  • Bexion Pharmaceuticals's estimated revenue per employee is $155,000

Employee Data

  • Bexion Pharmaceuticals has 34 Employees.(i)
  • Bexion Pharmaceuticals grew their employee count by 6% last year.

Bexion Pharmaceuticals's People

NameTitleEmail/Phone
1
Founder and Chief Scientific OfficerReveal Email/Phone
2
President & CEOReveal Email/Phone
3
President & CEOReveal Email/Phone
4
Chief StaffReveal Email/Phone
5
Chief Operations OfficerReveal Email/Phone
6
Chief Financial OfficerReveal Email/Phone
7
Chief Medical OfficerReveal Email/Phone
8
VP Business DevelopmentReveal Email/Phone
9
VPReveal Email/Phone
10
VP Research & DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$0.9M60%N/AN/A
#3
$2.6M176%N/AN/A
#4
$4.3M28-32%N/AN/A
#5
$499.4M32223%N/AN/A
#6
$0.8M50%N/AN/A
#7
$3.6M2328%N/AN/A
#8
$0.8M50%N/AN/A
#9
$4M2618%N/AN/A
#10
$31.8M205-14%N/AN/A
Add Company

What Is Bexion Pharmaceuticals?

Bexion Pharmaceuticals is committed to the discovery and clinical development of life-changing oncology treatments. We focus on helping patients and their families living with cancer, where there is a significant unmet need. Bexion has initiated a robust clinical development plan to develop safe, effective treatments across multiple indications. Our company founder and leadership team have deep experience across pharmaceutical operations, discovery, research and development, manufacturing, clinical, regulatory, and commercialization. The Bexion team is driven by the promise of developing life-changing oncology therapies on our path to become a leading biotech company. Bexion has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for Glioblastoma Multiforme (GBM) and Malignant Glioma including Diffuse Intrinsic Pontine Giloma (DIPG) To learn more about Bexion Pharmaceuticals, please visit Bexionpharma.com or contact Margaret M. van Gilse at (859) 446-7386 or mvangilse@bexionpharma.com

keywords:N/A

N/A

Total Funding

34

Number of Employees

$5.3M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A343%N/A
#2
$6.8M34-3%N/A
#3
$9.2M356%N/A
#4
$7.2M366%N/A
#5
$9.4M363%N/A